Publications of F. Holsboer

Yehuda, R.; Flory, J. D.; Pratchett, L. C.; Buxbaum, J.; Ising, M.; Holsboer, F.: Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology 212 (3), pp. 405 - 417 (2010)

Dahlhoff, M.; Siegmund, A.; Golub, Y.; Wolf, E.; Holsboer, F.; Wotjak, C. T.: AKT/GSK-3 beta/beta-catenin signalling within hippocampus and amygdala reflects genetically determined differences in posttraumatic stress disorder like symptoms. Neuroscience 169 (3), pp. 1216 - 1226 (2010)

Knapman, A.; Heinzmann, J. M.; Holsboer, F.; Landgraf, R.; Touma, C.: Modeling psychotic and cognitive symptoms of affective disorders: Disrupted latent inhibition and reversal learning deficits in highly stress reactive mice. Neurobiology of Learning and Memory 94 (2), pp. 145 - 152 (2010)

Hennings, J.; Kohli, M.; Heck, A.; Roeske, D.; Brückl, T.; Klengel, T.; Menke, A.; Müller-Myhsok, B.; Ising, M.; Holsboer, F. et al.; Lucae, S.: Polymorphisms in the BDNF gene are associated with antidepressant treatment response. European Neuropsychopharmacology 20 (Suppl. 3), pp. S427 - S428 (2010)

Lewis, C. M.; Ng, M. Y.; Butler, A. W.; Cohen-Woods, S.; Uher, R.; Pirlo, K.; Weale, M. E.; Schosser, A.; Paredes, U. M.; Rivera, M. et al.; Craddock, N.; Owen, M. J.; Jones, L.; Jones, I.; Korszun, A.; Aitchison, K. J.; Shi, J. X.; Quinn, J. P.; MacKenzie, A.; Vollenweider, P.; Waeber, G.; Heath, S.; Lathrop, M.; Muglia, P.; Barnes, M. R.; Whittaker, J. C.; Tozzi, F.; Holsboer, F.; Preisig, M.; Farmer, A. E.; Breen, G.; Craig, I. W.; McGuffin, P.: Genome-Wide Association Study of Major Recurrent Depression in the UK Population. American Journal of Psychiatry 167 (8), pp. 949 - 957 (2010)

Deussing, J. M.; Breu, J.; Kühne, C.; Kallnik, M.; Bunck, M.; Glasl, L.; Yen, Y. C.; Schmidt, M. V.; Zurmühlen, R.; Vogl, A. M. et al.; Gailus-Durner, V.; Fuchs, H.; Hölter, S. M.; Wotjak, C. T.; Landgraf, R.; de Angelis, M. H.; Holsboer, F.; Wurst, W.: Urocortin 3 Modulates Social Discrimination Abilities via Corticotropin-Releasing Hormone Receptor Type 2. Journal of Neuroscience 30 (27), pp. 9103 - 9116 (2010)

Ditzen, C.; Varadarajulu, J.; Czibere, L.; Gonik, M.; Targosz, B. S.; Hambsch, B.; Bettecken, T.; Kessler, M. S.; Frank, E.; Bunck, M. et al.; Teplytska, L.; Erhardt, A.; Holsboer, F.; Mueller-Myhsok, B.; Landgraf, R.; Turck, C. W.: Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways. Molecular Psychiatry 15 (7), pp. 702 - 711 (2010)

Kloiber, S.; Kohli, M. A.; Brueckl, T.; Ripke, S.; Ising, M.; Uhr, M.; Menke, A.; Unschuld, P. G.; Horstmann, S.; Salyakina, D. et al.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.; Lucae, S.: Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 15 (7), pp. 736 - 747 (2010)

Knapman, A.; Heinzmann, J. M.; Hellweg, R.; Holsboer, F.; Landgraf, R.; Touma, C.: Increased stress reactivity is associated with cognitive deficits and decreased hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders. Journal of Psychiatric Research 44 (9), pp. 566 - 575 (2010)

Muglia, P.; Tozzi, F.; Galwey, N. W.; Francks, C.; Upmanyu, R.; Kong, X. Q.; Antoniades, A.; Domenici, E.; Perry, J.; Rothen, S. et al.; Vandeleur, C. L.; Mooser, V.; Waeber, G.; Vollenweider, P.; Preisig, M.; Lucae, S.; Müller-Myhsok, B.; Holsboer, F.; Middleton, L. T.; Roses, A. D.: Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Molecular Psychiatry 15 (6), pp. 589 - 601 (2010)

Nothdurfter, C.; Tanasic, S.; Di Benedetto, B.; Rammes, G.; Wagner, E. M.; Kirmeier, T.; Ganal, V.; Kessler, J. S.; Rein, T.; Holsboer, F. et al.; Rupprecht, R.: Impact of Lipid Raft Integrity on 5-HT3 Receptor Function and its Modulation by Antidepressants. Neuropsychopharmacology 35 (7), pp. 1510 - 1519 (2010)

Schmidt, M. V.; Scharf, S. H.; Sterlemann, V.; Ganea, K.; Liebl, C.; Holsboer, F.; Müller, M. B.: High susceptibility to chronic social stress is associated with a depression-like phenotype. Psychoneuroendocrinology 35 (5), pp. 635 - 643 (2010)

Unschuld, P. G.; Ising, M.; Roeske, D.; Erhardt, A.; Specht, M.; Kloiber, S.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.; Binder, E. B.: Gender-Specific Association of Galanin Polymorphisms with HPA-Axis Dysregulation, Symptom Severity, and Antidepressant Treatment Response. Neuropsychopharmacology 35 (7), pp. 1583 - 1592 (2010)

Hennings, J. M.; Kohli, M. A.; Heck, A.; Roeske, D.; Horstmann, S.; Brückl, T.; Klengel, T.; Menke, A.; Müller-Myhsok, B.; Ising, M. et al.; Holsboer, F.; Lucae, S.: Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response. Biological Psychiatry 67 (9 Suppl.1), pp. 127S - 128S (2010)

Holsboer, F.: Future Perspectives of Depression Research. Biological Psychiatry 67 (9 Suppl.1), pp. 1S - 2S (2010)

Horstmann, S.; Ising, M.; Adena, S.; Pfenning, A.; Modell, S.; Bettecken, T.; Müller-Myhsole, B.; Holsboer, F.; Binder, E. B.: Fine-Mapping of Genetic Loci Linked to REM-Density in the Munich Vulnerability Study. Biological Psychiatry 67 (9 Suppl.1), p. 128S - 128S (2010)

Kloiber, S.; Roeske, D.; Müller-Myhsok, B.; Hennings, J.; Holsboer, F.; Lucae, S.: Genome-Wide Association Study of Body Weight in Patients with Major Depression. Biological Psychiatry 67 (9 Suppl.1), p. 128S - 128S (2010)

Menke, A.; Puetz, B.; Weber, P.; Eichelkraut, A.; Rex-Haffner, M.; Klengel, T.; Gonik, M.; Uhr, M.; Deussing, J.; Holsboer, F. et al.; Müller-Myhsok, B.; Binder, E. B.: Genome-Wide Gene-Expression Profiles Following Glucocorticoid Stimulation Associated with Major Depression. Biological Psychiatry 67 (9 Suppl.1), p. 129S - 129S (2010)

Seemüller, F.; Riedel, M.; Obermeier, M.; Bauer, M.; Adli, M.; Kronmüller, K.; Holsboer, F.; Brieger, P.; Laux, G.; Bender, W. et al.; Heuser, I.; Zeiler, J.; Gaebel, W.; Dichgans, E.; Bottländer, R.; Musil, R.; Möller, H. J.: Outcomes of 1014 naturalistically treated inpatients with major depressive episode. European Neuropsychopharmacology 20 (5), pp. 346 - 355 (2010)

Thoeringer, C. K.; Erhardt, A.; Sillaber, I.; Mueller, M. B.; Ohl, F.; Holsboer, F.; Keck, M. E.: Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice. Journal of Psychopharmacology 24 (5), pp. 733 - 743 (2010)